Article Text

PDF

High compared with standard dose lipase pancreatic supplement.
  1. P J Robinson,
  2. A Olinsky,
  3. A L Smith,
  4. S B Chitravanshi
  1. Professorial Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.

    Abstract

    Cotazym-S-Forte, a new pancreatic supplement containing 10,000 BP units of lipase activity per capsule, was compared with a standard dose pancreatin supplement (Pancrease) with 5000 BP units lipase activity in a randomised crossover trial. The number of capsules of Cotazym-S-Forte administered was half the usual number of Pancrease capsules and was associated with the same degree of fat absorption as Pancrease.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.